A Guide To Choosing A Modern Pharmacovigilance Solution

Managing workloads in pharmacovigilance operations has never been so arduous. The magnitude of safety data currently available—from both traditional and non-traditional sources—is already straining teams and challenging organizations, and it will only continue to grow.

The IDC estimates case volumes are growing 30–50% each year, driven by multiple factors, including new, digital reporting channels and more treatments for rare and complex diseases.

More and more safety teams recognize that disjointed, labor-intensive safety workflows are a major obstacle. These traditional workflows are time-consuming, don’t scale, impair compliance agility, and drain resources.

Across the life sciences industry, firms of all sizes realize that a modern approach is necessary and possible with an end-to-end, unified, and automated safety solution. Such a modern approach to pharmacovigilance:

• Enables greater operational and financial efficiency
• Harmonizes and streamlines global processes
• Frees resources for a more proactive and strategic safety posture

The question you face today is not “if” safety should be modernized but “how.”